tiprankstipranks
MoonLake Immunotherapeutics announces anticipated events
PremiumThe FlyMoonLake Immunotherapeutics announces anticipated events
2M ago
MoonLake Immunotherapeutics reports Q1 EPS (22c), consensus (19c)
PremiumThe Fly
MoonLake Immunotherapeutics reports Q1 EPS (22c), consensus (19c)
2M ago
MoonLake Immunotherapeutics Reports First Quarter 2024 Financial Results and Provides a Business Update
PremiumPress Releases
MoonLake Immunotherapeutics Reports First Quarter 2024 Financial Results and Provides a Business Update
2M ago
MoonLake Immunotherapeutics initiated with a Neutral at Goldman Sachs
PremiumThe FlyMoonLake Immunotherapeutics initiated with a Neutral at Goldman Sachs
3M ago
Ascendis, MoonLake Immunotherapeutics removed from Best Ideas List at Wedbush
PremiumThe Fly
Ascendis, MoonLake Immunotherapeutics removed from Best Ideas List at Wedbush
4M ago
3 Best Stocks to Buy Now, 3/14/2024, According to Top Analysts 
PremiumMarket News
3 Best Stocks to Buy Now, 3/14/2024, According to Top Analysts 
4M ago
3 Best Stocks to Buy Now, 3/5/2024, According to Top Analysts 
PremiumMarket News3 Best Stocks to Buy Now, 3/5/2024, According to Top Analysts 
4M ago
MoonLake Immunotherapeutics to present MIRA trial data of Nanobody® sonelokimab in hidradenitis suppurativa as a late breaker at the AAD Annual Meeting 2024
PremiumPress Releases
MoonLake Immunotherapeutics to present MIRA trial data of Nanobody® sonelokimab in hidradenitis suppurativa as a late breaker at the AAD Annual Meeting 2024
4M ago
MoonLake Immunotherapeutics price target raised to $80 from $77 at Guggenheim
PremiumThe Fly
MoonLake Immunotherapeutics price target raised to $80 from $77 at Guggenheim
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100